KemPharm's Series B Round

KemPharm raised a round of funding on September 17, 2009. Investors include DeWaay Investment Partners.

KemPharm is a biopharmaceutical company focused on the discovery and development of new chemical entities (NCEs) to treat serious medical conditions through its proprietary and broadly applicable Liga…

Articles about KemPharm's Series B Round: